Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-030926
Filing Date
2014-05-15
Accepted
2014-05-15 11:15:24
Documents
12
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v377437_10q.htm 10-Q 220862
2 EXHIBIT 3.1 v377437_ex3-1.htm EX-3.1 26735
3 EXHIBIT 31.1 v377437_ex31-1.htm EX-31.1 9177
4 EXHIBIT 31.2 v377437_ex31-2.htm EX-31.2 9636
5 EXHIBIT 32.1 v377437_ex32-1.htm EX-32.1 4694
6 EXHIBIT 32.2 v377437_ex32-2.htm EX-32.2 4670
  Complete submission text file 0001144204-14-030926.txt   3269398

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ibio-20140331.xml EX-101.INS 395521
8 XBRL TAXONOMY EXTENSION SCHEMA ibio-20140331.xsd EX-101.SCH 41620
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ibio-20140331_cal.xml EX-101.CAL 23188
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ibio-20140331_def.xml EX-101.DEF 198694
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ibio-20140331_lab.xml EX-101.LAB 255468
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ibio-20140331_pre.xml EX-101.PRE 238290
Mailing Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711
Business Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35023 | Film No.: 14844773
SIC: 2834 Pharmaceutical Preparations